Physician profile
Kenneth R Lander
NPI 1154318988
$646,767.75
in general payments reported to CMS, 2019-2025
48 companies · $163K in 2025
The $163K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $24K · 2021: $50K · 2022: $53K · 2023: $162K · 2024: $163K · 2025: $163K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $416K · Travel and Lodging: $49K · Food and Beverage: $24K · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $415,750.00 |
| Travel and Lodging | $48,565.89 |
| Food and Beverage | $23,660.56 |
| Education | $289.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $590,354.64 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Mallinckrodt Enterprises LLC | $23,296.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,380.64 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Mallinckrodt Hospital Products INC. | $5,521.17 | 2020-2025 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $3,161.76 | 2019-2025 | |
| Glaxosmithkline, LLC. | $2,784.13 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Harmony Biosciences LLC | $1,430.55 | 2021-2025 | Wakix |
| Insmed, INC. | $1,089.29 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $1,029.41 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $934.59 | 2020-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $902.79 | 2019-2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $746.80 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $696.52 | 2020-2025 | Aralast, Cuvitru |
| Mylan Specialty L.P. | $632.02 | 2019-2024 | Yupelri |
| Philips North America LLC | $593.21 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $550.90 | 2019-2025 | Tyvaso, Tyvaso |
| Axsome Therapeutics, INC. | $531.25 | 2022-2025 | Sunosi |
| Ani Pharmaceuticals, INC. | $441.59 | 2022-2025 | Purified Cortrophin Gel |
| Grifols USA, LLC | $424.68 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Sunovion Pharmaceuticals INC. | $392.92 | 2019-2021 | |
| Baxter Healthcare | $391.68 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $340.30 | 2021-2024 | |
| Electromed, INC. | $339.82 | 2021-2025 | Smartvest |
| Amgen INC. | $196.97 | 2022-2025 | Tezspire |
| Inogen, INC. | $182.46 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genentech USA, INC. | $177.10 | 2019-2021 | |
| Verona Pharma, INC. | $160.70 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $135.82 | 2025 | Yupelri |
| Pulmonx Corporation | $97.98 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Advanced Respiratory, INC | $92.25 | 2019-2020 | |
| Vifor Pharma, INC. | $87.33 | 2024-2025 | Zemaira, Veltassa |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Inspire Medical Systems, INC. | $74.89 | 2024-2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $58.23 | 2023 | Nuzyra |
| Tactile Systems Technology INC | $57.73 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Circassia INC. | $49.95 | 2019 | |
| Alexion Pharmaceuticals, INC. | $42.66 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $41.57 | 2025 | Lumryz |
| Janssen Biotech, INC. | $39.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $33.14 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $32.66 | 2021-2024 | Winrevair |
| Covis Pharma Gmbh | $31.11 | 2022-2023 | |
| Lilly USA, LLC | $30.00 | 2025 | Zepbound |
| E.R. Squibb & Sons, L.L.C. | $24.23 | 2025 | Camzyos |
| Astellas Pharma US INC | $22.69 | 2023 | Cresemba |
| Pfizer INC. | $21.97 | 2021 | |
| Shire North American Group INC | $17.30 | 2019 | |
| Nabriva Therapeutics, Plc | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.